3 results found
The US-India biotech collaboration under TRUST is more than a bilateral game; it can help reshape global value chains and promote inclusive, ethical i
The COVID-19 pandemic, in India, illustrated the need to enhance the country’s capabilities in confronting biological threats, particularly through early detection and timely intervention. Although the pandemic has ended, the threat of new and re-emerging zoonotic viruses remains, the most recent cases being the Nipah virus (NiV) and Guillain-Barré syndrome (GBS) outbreaks; there is also the risk of accidental or intentional biological threats
